Clinical Trials Logo
  1. Home
  2. Atrial Fibrillation (AF)
  3. NCT02630914

Medical and Surgical Hybrid Treatment of Atrial Fibrillation. — HT2AF  

Atrial Fibrillation (AF) Clinical Trial

Official title:
Medical and Surgical Hybrid Treatment of Atrial Fibrillation: Epicardial and Endocardial Combined Approach.

Clinical Trial Summary

The objective of the study is to investigate the feasibility of a hybrid procedure removal of the atrial fibrillation.

This is a single procedure for both surgical epicardial by minimally invasive route (Thoracoscopy) without even flow controlled and supplemented if necessary by extra corporeal intracavitary route at the same time.

This faster procedure combined with complete lesions have a higher success rate and less frequent re-hospitalizations of patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02630914
Study type Interventional
Source University Hospital, Toulouse
Contact
Status Completed
Phase N/A
Start date September 2015
Completion date March 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT05410379 - Antral Lesions Characterization of a New Cryoballoon Ablation System in Terms of Local Impedance Drop
Enrolling by invitation NCT05407415 - KardiaMobile ECG Monitoring Effects on Health Care Utilization and Patient Experience With Atrial Fibrillation N/A
Completed NCT04025710 - Master Study of the BIOMONITOR III and Incision and Insertion Tool (FIT OneStep) N/A
Completed NCT01119274 - EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon Phase 4
Recruiting NCT03428048 - Cardiovascular Innovation & Research Institute 's NEXUS Registry, the Whole is Greater Than the Parts.
Recruiting NCT04298723 - Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding. N/A
Completed NCT04218266 - Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications. Phase 2
Active, not recruiting NCT03732794 - AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment N/A
Active, not recruiting NCT04755283 - Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation Phase 2
Completed NCT04095559 - Characterization of Left Atrial Substrate by Comparison of Bipolar Voltage Maps With Standard Focal 4.5 mm Tip Electrode, 1 mm Ring Electrode, and Microelectrode Catheters Using InTEllaMap Orion and IntellaNav MIFI O
Recruiting NCT05712200 - Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76) Phase 3
Recruiting NCT05955365 - Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation Phase 4
Recruiting NCT05294445 - From the Emergency Department Directly to Ablation of Atrial Fibrillation Study N/A
Completed NCT02513316 - Clinical Relevance of Microbleeds In Stroke N/A
Completed NCT04809922 - Accuracy of Cardiac Wearables Devices to Detect Atrial Fibrillation